In this study, we evaluated the frequencies and clinic-pathological characteristics of RAS mutation, BRAF mutation and DNA mismatch repair expression in Chinese patients with sporadic stage I-IV colorectal cancers, and studied the molecular heterogeneity of patients with different tumor site. This evidence concerns the gene BRAF and colorectal cancer.